Comparative characteristics of the state of the immune system in patients with coronary artery disease with stable angina pectoris and acute coronary syndrome

Main Article Content

O. M. Lomakovsky
T. I. Gavrilenko
O. M. Parkhomenko
M. І. Lutay
O. A. Pidgaina
N. O. Rizhkova

Abstract

The aim – to assess the relationship between the state of the immune system and the development of acute coronary syndrome in patients with IHD.
Materials and methods. The first group consisted of 64 patients with ST-segment elevation acute coronary syndrome, mean age 54 (49–64) years; the second group – 223 patients with coronary artery disease with stable exertional angina, FC II–III, mean age 56 (49–63) years; the third group – 47 patients with acute coronary syndrome without ST segment elevation, mean age 61 (52–65) years. The material for the immunological study was peripheral venous blood. To determine the parameters of cellular and humoral innate and adaptive immunity in blood serum and supernatants of mononuclear cells, enzyme immunoassay was used.
Results and discussion. In patients with coronary artery disease with acute coronary syndrome with ST segment elevation compared with patients with coronary artery disease with stable angina pectoris, the levels of indicators of the immune status in the blood were: CRP – 9.3 (5.3–12.0) versus 4.8 (2.4–8.1) mg/L (p=0.0001), sICAM – 785 (690–830) versus 565 (406–744) ng/ml (p=0.0001), IL-10 in blood mononuclear cells – 48 (1–228) versus 194 (21–758) pg/ml (p=0.0007), circulating immune complexes – 90 (70–108) versus 76 (54–105) od. (p=0.045), lymphocytes with apoptosis (CD95) – 16 (9–27) versus 11 (8–17) % (p=0.029), spontaneous oxygen-dependent metabolism of monocytes – 16 (12–21) versus 13 (9–17) (p=0.001). The levels of indicators of the immune system in the blood in patients with coronary artery disease with acute coronary syndrome with ST segment elevation compared with patients with coronary artery disease with acute coronary syndrome without ST segment elevation were: T-helpers – 37 (32–41) versus 42 (37–48) % (p=0.0006) (R=–0.33; p=0.0005), reaction of lymphocyte blast transformation to nonspecific antigen – 38 (32–47) versus 50 (42–61) % (p=0.0004) (R=–0.37; p=0.0003).
Conclusions. The development of acute coronary syndrome is directly combined with increased activity of the immune system, as evidenced by the high production of proinflammatory CRP, IL-8, sICAM with a low level of anti-inflammatory IL-10, a pronounced humoral adaptive immune response (in terms of antibodies to the myocardium and vascular tissues, CD40, circulating immune complexes) and active functional state of monocytes (according to cNCT test, functional reserve, phagocytosis) in patients with coronary artery disease with acute coronary syndrome, regardless of the position of the ST segment in comparison with patients with stable coronary artery disease. Elevated levels of antibodies to the myocardium in patients with stable coronary heart disease indicate moderate myocardial damage due to temporary ischemia in angina attacks, even with a stable course of the disease. In patients with acute coronary syndrome, high levels of antibodies to the myocardium indicate myocardial damage due to increased ischemia in plaque destabilization much earlier than the clinical manifestations of acute coronary syndrome. In acute coronary syndrome with ST-segment elevation, compared with ACS patients without ST-segment elevation, activation of neutrophils and suppression of the activity of adaptive T-cell immunity is noted (by the level of T-helpers, sCD40L, blast transformation of lymphocytes, γ-interferon in mononuclear cells, apoptosis of lymphocytes).

Article Details

Keywords:

innate immunity, adaptive immunity, acute coronary syndrome, stable angina pectoris

References

Бебешко В.Г., Чумак А.А., Базыка Д.А., Беляева Н.В. Моноклональные антитела в радиационной иммунологии: Методические рекомендации.– К., 1993.– 19 с.

Братусь В.В., Талаева Т.В. Воспаление как патогенетическая основа атеросклероза // Укр. кардіол. журн.– 2007.– № 1.– С. 90–96.

Зорин Н.А., Подхомутников В.М., Янкнн М.Ю. и др. Реактан­ты острой фазы воспаления и интерлейкин-8 при инфаркте мио­карда // Клиническая лабораторная диагностика.– 2009.– № 4.– С. 36–47.

Зорина В.Н., Белоконева К.П., Бичан Н.А. Реактанты острой фазы воспаления и провоспалительные цитокины при различ­ных осложнениях инфаркта миокарда // Клиническая лаборатор­ная диагностика.– 2012.– № 1.– С. 28–30.

Зыков К.А., Иуралнев Э.Ю., Казначеева Е.И. и др. Дина­­ми­ка воспалительного процесса у больных с острым коронарным синдромом и стабильной стенокардией. Сообщение И. Биохи­мические, иммунологические и клинические аспекты // Кардио­логический вестник.– 2011.– № 1.– С. 23–32.

Кондрашова Н.И. Реакция потребления комплемента в новой постановке для выявления противотканевых антител // Лаб. дело.– 1974.– № 9.– С. 552–554.

Оганов Р.Г., Закирова Н.Э., Закирова А.Н. и др. Иммуновоспалительные реакции при остром коронарном синдроме // Рациональная фармакотерапия в кардиологии.– 2007.– № 5.– С. 15–19.

Применение проточной цитометрии для оценки функциональной активности иммунной системы человека: Пособие для врачей-лаборантов.– М., 2001.– 53 с.

Рагино Ю.И., Куимов А.Д., Полонская Я.В. и др. Динамика из­менений воспалительно-окислительных биомаркеров в крови при остром коронарном синдроме // Кардиология.– 2012.– № 2.– С. 18–22.

Смакаева Э.Р., Хасанова А.Р., Галлямова В.Р. и др. Маркеры воспаления при остром коронарном синдроме // Профилактиче­ская медицина.– 2009.– № 6.– С. 44–55.

Стандартизация методов иммунофенотипирования клеток крови и костного мозга человека (рекомендации рабочей группы СПб РО РААКИ) // Мед. иммунология.– 1999.– Т. 5, № 1.– С. 21–43.

Стефани Д.Ф., Вельтищев Ю.Е. Клиническая иммунология и иммунопатология детского возраста.– М.: Медицина, 1996.– 372 с.

Столов С.В., Мазуров В.И., Зарайский М.И. и др. Роль провоспалительных цитокинов в развитии коронарного атероскле­роза // Медицинский академический журнал.– 2004.– № 1.– С. 42–48.

Унифицированные иммунологические методы обследования больных на стационарном и амбулаторном этапах лечения: Метод. рекомендации. Киевский НИИ фтизиатрии и пульмонологии.– К., 1988. – 18 с.

Уразгильдеева С.А., Шаталина Л.В., Денисенко А.Д. и др. Взаимосвязь между уровнем холестеринсодержащих иммунных комплексов и чувствительностью липопротеидов к перекисному окислению у больных ишемической болезнью сердца // Кардиология.– 1997.– № 10.– С. 17–20.

Шевченко О.П., Слюсарева Г.С., Шевченко А.О. РАРР-А и другие маркеры воспаления в диагностике острого коронарного синдрома // Профилактическая медицина.– 2009.– № 6.– С. 57.

Шрейдер Е.В., Шахнович P.M., Казначеева Е.И. и др. Прогно­стическое значение маркеров воспаления и NT-proBNP при раз­личных вариантах лечения пациентов с ОКС // Кардиологический вестник.– 2008.– № 2.– С. 7–14.

Abbate A., Dinarello C.A. Antiinflammatory therapies in acute coronary syndromes: is IL-1 blockade a solution? // Eur. Heart J.– 2015.– Vol. 36 (6).– P. 337–339. doi: 10.1093/eurheartj/ehu369.

Biasucci L.M., Liuzzo G., Giubilato S. et al. Delayed neutrophil apoptosis in patients with unstable angina: relation to C-reactive protein and recurrence of instability // Eur. Heart J.– 2009.– Vol. 30 (18).– P. 2220–2225. doi: 10.1093/eurheartj/ehp248.

Brunetti D.N., Correale M., Pellegrino P.L. et al. Early inflammatory cytokine response: A direct comparison between spontaneous coronary plaque destabilization vs angioplasty induced // Atherosclerosis.– 2014.– Vol. 236 (2).– P. 456–460. doi: 10.1016/j.atherosclerosis.2014.07.037.

Conti C.R. C-reactive protein and ST-segment elevation myocardial infarction discordance // J. Am. Coll. Cardiol.– 2011.– Vol. 58 (25).– P. 2662–2663. doi: 10.1016/j.jacc.2011.09.027.

Croce K., Libby P. Stirring the soup of innate immunity in the acute coronary syndromes // Eur. Heart J.– 2010.– Vol. 31 (12).– P. 1430–1432. doi: 10.1093/eurheartj/ehq085.

De Oliveira R.T., Mamoni R.L., Souza J.R.M. et al. Differential expression of cytokines, chemokines and chemokine receptors in patients with coronary artery disease // Intern. J. Cardiology.– 2009.– Vol. 136 (1).– P. 17–26. doi: 10.1016/j.ijcard.2008.04.009.

Dentali F., Nigro O., Squizzato A. et al. Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature // Intern. J. Cardiology.– 2018.– Vol. 266 (1).– P. 31–37. doi: 10.1016/j.ijcard.2018.02.116.

Digeon M., Caser M., Riza J. Detection of immune complexes in human sera by simplified assays with polyethylene glycol // Immunol. Methods.– 1977.– Vol. 226.– P. 497–509. doi: 10.1016/0022-1759 (77)90051-5.

Frantz S., Hofmann U. Monocytes on the Scar’s Edge // J. Am. Coll. Cardiol.– 2012.– Vol. 59 (2).– P. 164–165. doi: 10.1016/j.jacc.2011.09.047.

Haeusler K.G., Schmidt W.U.H., Foehring F., Meisel C. Immune responses after acute ischemic stroke or myocardial infarction // Intern. J. Cardiology.– 2012.– Vol. 155 (3).– P. 372–377. doi: 10.1016/j.ijcard.2010.10.053.

Hofmann U., Frantz S. Role of T-cells in myocardial infarction You have access // Eur. Heart J.– 2016.– Vol. 37 (11).– P. 873–879. doi: 10.1093/eurheartj/ehv639.

Junhong W., Bo Tang, Xinjian Liu et al. Increased monomeric CRP levels in acute myocardial infarction: A possible new and specific biomarker for diagnosis and severity assessment of disease // Atherosclerosis.– 2015.– Vol. 239 (2).– P. 343–349. doi: 10.1016/j.atherosclerosis.2015.01.024.

Liuzzo G., Biasucci L.M., Trotta G. et al. Unusual CD4+CD28null T lymphocytes and recurrence of acute coronary events // J. Am. Coll. Cardiol.– 2007.– Vol. 50.– P. 1450–1458. doi: 10.1016/j.jacc.2007.06.040.

Monteleone I., Muscoli S., Terribili N., Zorzi F. Local immune activity in acute coronary syndrome: oxLDL abrogates LPS-tolerance in mononuclear cells isolated from culprit lesion // Intern. J. Cardiology.– 2013.– Vol. 169 (1).– P. 44–51. doi: 10.1016/j.ijcard.2013.08.082.

Morton A.C., Rothman A.M.K., Greenwood J.P. et al. The effect of interleukin1 receptor antagonist therapy on markers of inflammation in nonST elevation acute coronary syndromes: the MRC-ILA Heart Study // Eur. Heart J.– 2015.– Vol. 36 (6).– P. 377–384. doi: 10.1093/eurheartj/ehu272.

Muhl H., Kunz D., Pfeilschifter J. Expression nitric oxide synthase in rat glomerular mesangial cells mediated by cyclic AMP // Br. J. Pharmacol.– 1994.– Vol. 112.– P. 1–8. doi: 10.1111/j.1476-5381.1994.tb13019.x.

Nahrendorf M., Frantz S. Swirski imaging systemic inflammatory networks in ischemic heart disease // J. Am. Coll. Cardiol.– 2015.– Vol. 65 (15).– P. 1583–1591. doi: 10.1016/j.jacc.2015.02.034.

Park J.J., Jang H.-J., Oh I.-Y. Prognostic Value of Neutrophil to Lymphocyte Ratio in Patients Presenting With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention // The American Journal of Cardiology.– 2013.– Vol. 111 (5).– P. 636–642. doi: 10.1016/j.amjcard.2012.11.012.

Schiele F., Meneveau N., Seronde M.F., Chopard R. C-reactive protein improves risk prediction in patients with acute coronary syndromes // Eur. Heart J.– 2010.– Vol. 31 (3).– P. 290–297. doi: 10.1093/eurheartj/ehp273.

Seropian I.M., Toldo S., Van Tassell B.W., Abbate A. Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction // J. Am. Coll. Cardiol.– 2014.– Vol. 63 (16).– P. 1593–1603. doi: 10.1016/j.jacc.2014.01.014.

Snell F.D., Snell C.T. Colorymetric methods of analysis.– N.Y.: Van Nostard.– 1984.– P. 560.

Van der Laan A.M., Hirsch A., Robbers L. F.H.J., Nijveldt R. A proinflammatory monocyte response is associated with myocardial injury and impaired functional outcome in patients with ST-segment elevation myocardial infarction // Amer Heart J.– 2012.– Vol. 163 (1).– P. 57–65. doi: 10.1016/j.ahj.2011.09.002.

Wang Y., Xie Y., Ma H. et al. Regulatory T lymphocytes in myocardial infarction: A promising new therapeutic target // Intern. J. Cardiology.– 2016.– Vol. 203.– P. 923–928. doi: 10.1016/j.ijcard.2015.11.078.

Yoshioka T., Funayama H., Hoshino H. et al. Association of CD40 ligand levels in the culprit coronary arteries with subsequent prognosis of acute myocardial infarction // Atherosclerosis.– 2010.– Vol. 213 (1).– P. 268–272. doi: 10.1016/j.atherosclerosis.2010.07.044.

Zhao Z., Wu Y., Cheng M., Ji Y., Yang X., Liu P. Activation of Th17/Th1 and Th1, but not Th17, is associated with the acute cardiac event in patients with acute coronary syndrome // Atherosclerosis.– Vol. 217 (2).– P. 518–524. doi: 10.1016/j.atherosclerosis.2011.03.043.

Most read articles by the same author(s)

<< < 1 2 3 4